TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 6, Issue 3, 2019
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
Purchase
Abstract
Title
ADVANCED MANAGEMENT OF DIABETIC RETINOPATHY - A REVIEW
Author
Singh Vijay Kumar , Pandey Shireen , Ahmad Naeem* , Bashir Taseer , Gaur Abhishek , Ahmad Nadeem
Email
vijaydr06@gmail.com
keyword
Retinopathy, Eyeball, Diabetes, Patho-physiology.
Abstract
Diabetic retinopathy (DR) has been established as one of the most significant risk factor for blindness worldwide. Blood pressure & metabolic control has been shown to significantly decrease the risk of retinopathy and remains a benchmark in the management of DR. There are many tools for preventing DR and its complications. Although treatment can help prevent blindness in majority of cases, still the key variable behind success of treatment stays with accurate diagnosis of patients with retinopathy before their vision is fully affected. Hence the key lies in the timely eye examination of diabetic patients. In the present review article the advanced pharmacological methods to target biochemical pathways causing DR are being evaluated here to overcome present treatment limitations.
Back to Top >>>>